HealthcareServices

Needle-Free Drug Delivery Devices Market Size and Demand Forecast 2026–2030

March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the needle-free drug delivery devices market from 2026–2035 with trusted insights from The Business Research Company

How is the Needle-Free Drug Delivery Devices Market size predicted to change over the forecast window of 2026–2035?

In recent years, the size of the needle-free drug delivery devices market has experienced rapid expansion. This market is projected to grow from $18.54 billion in 2025 to $20.65 billion in 2026, at a compound annual growth rate (CAGR) of 11.4%. The increase observed in the past can be attributed to several factors, including patients’ fear of needles, the rising demand for safer injection options, an increase in infectious disease vaccinations, the limitations inherent in traditional needle-based methods, and initial progress in jet injection mechanisms.

The needle-free drug delivery devices market size is expected to experience robust growth in the upcoming years. It is projected to expand to $29.91 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.7%. This anticipated growth is primarily driven by factors such as the increasing prevalence of chronic diseases, the rising adoption of self-administration therapies, the expansion of telemedicine and remote care, a growing demand for minimally invasive drug delivery solutions, and continuous advancements in microneedle and transdermal technologies. Significant trends for the forecast period include an escalating demand for painless drug delivery methods, a surge in the adoption of home-based drug delivery solutions, the increasing utilization of needle-free devices in pediatric applications, an uptick in self-administration treatments for chronic diseases, and the wider expansion of needle-free vaccine delivery systems.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15615&type=smp

Which Drivers Are Contributing To The Expansion Of The Needle-Free Drug Delivery Devices Market?

The rising incidence of diabetes is projected to fuel the expansion of the needle-free drug delivery device market in the future. Diabetes is a chronic health condition characterized by elevated blood glucose levels, stemming from insufficient insulin creation or the body’s inefficient utilization of insulin. The global increase in diabetes cases can be attributed to factors such as inactive lifestyles, poor eating habits, genetic factors, urban development, an aging populace, along with restricted healthcare access and growing obesity rates. Needle-free drug delivery devices offer an alternative method for administering insulin in diabetes management, bypassing traditional injections. These devices employ technologies like jet injectors or transdermal patches to deliver insulin subcutaneously without needles, thereby reducing the discomfort and apprehension typically associated with injections and improving patient comfort. For instance, in June 2024, the National Health Service, a UK-based government department, reported that in 2023, the NHS identified an additional 549,000 individuals in England at risk of developing type 2 diabetes. This brought the overall count of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP, to 3,615,330. This figure marks a substantial rise from 3,065,825 recorded in 2022, indicating an increase of nearly 20%. Consequently, the expanding occurrence of diabetes is propelling the growth of the needle-free drug delivery device market.

What Segment Classifications Make Up The Needle-Free Drug Delivery Devices Market?

The needle-free drug delivery devices market covered in this report is segmented –

1) By Device Type: Inhalers, Jet Injectors, Novel Needles, Transdermal Patches

2) By Application: Pain Management, Vaccine Delivery, Pediatric Injections, Insulin Delivery, Other Applications

3) By End-User: Hospitals And Clinics, Home Healthcare

Subsegments:

1) By Inhalers: Dry Powder Inhalers (DPI), Metered Dose Inhalers (MDI), Nebulizers

2) By Jet Injectors: High-Pressure Jet Injectors, Spring-Powered Jet Injectors, Battery-Operated Jet Injectors

3) By Novel Needles: Micro-Needle Arrays, Nano-Needle Arrays

4) By Transdermal Patches: Microneedle Patches, Conventional Patches

Which Innovation Trends Are Advancing Developments Within The Needle-Free Drug Delivery Devices Market?

Leading companies within the needle-free drug delivery device market are concentrating on advanced solutions, such as dual chamber inhalers, to enhance administration ease and efficacy, thus addressing the evolving requirements of both patients and healthcare providers. A dual-chamber inhaler is defined as a device with two separate compartments for holding different medications. This design enables the combination of multiple drugs in a single inhaler, streamlining therapeutic processes and boosting patient convenience. For example, in April 2024, Berry Global, a US-based plastic manufacturing company, launched the BerryHaler, a cutting-edge dry powder inhaler (DPI) intended to innovate patient-centered healthcare solutions. This dual-chamber inhaler features a dose counter to guarantee accurate medication delivery. Its entirely plastic construction, lacking any metal parts, makes it well-suited for complex inhalation treatments, simplifying dosing and effectively combining various drugs. Among its advanced capabilities are a bi-directional mouthpiece cover for convenience and hygiene, along with audible indicators for correct usage. The integrated dose counter further helps in precisely monitoring medication consumption, preventing potential dosage inaccuracies.

Which Leading Companies Dominate The Needle-Free Drug Delivery Devices Market Share?

Major companies operating in the needle-free drug delivery devices market are 3M Company, Medtronic plc, Novo Nordisk AS, Becton Dickinson and Company, Insulet Corporation, MannKind Corporation, Med-Jet Inc., Portal Instruments, PharmaJet, National Medical Products Inc., Mika Medical Co. Ltd., Medical International Technology Inc. (MTI), NanoPass Technologies Ltd., PenJet Corporation, Akra Dermojet S.A., NuGen Medical Devices Inc., Crossject SA, Injex Pharma AG, Bayer AG, Antares Pharma Inc., Inovio Pharmaceuticals Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/needle-free-drug-delivery-devices-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Needle-Free Drug Delivery Devices Market?

North America was the largest region in the needle-free drug delivery devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the needle-free drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Needle-Free Drug Delivery Devices Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15615&type=smp

Browse Through More Reports Similar to the Global Needle-Free Drug Delivery Devices Market 2026, By The Business Research Company

Drug Delivery Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Drug Delivery Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Injectable Drug Delivery Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/injectable-drug-delivery-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795